Healthpeak Properties, Inc. (DOC) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
Healthpeak Properties, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $262,897,000.00Depreciation and amortization of real estate, in-place lease, and other intangibles → Operating adjustments reconciliation: $573,124,000.00Increase (decrease) in deferred revenue → Operating adjustments reconciliation: $78,968,000.00Decrease (increase) in accounts receivable and other assets → Operating adjustments reconciliation: $27,131,000.00Amortization of deferred financing costs and debt discounts (premiums) → Operating adjustments reconciliation: $17,264,000.00Stock-based compensation amortization expense → Operating adjustments reconciliation: $9,308,000.00Stock-based compensation issued as part of initial public offering of Janus Living, Inc. → Operating adjustments reconciliation: $4,872,000.00Distributions of earnings from unconsolidated joint ventures → Operating adjustments reconciliation: $905,000.00Loss (gain) on debt extinguishments → Operating adjustments reconciliation: $403,000.00Operating adjustments reconciliation → Net cash from operating activities: $359,084,000.00Operating adjustments reconciliation → Loss (gain) upon change of control, net: $138,343,000.00Operating adjustments reconciliation → Loss (gain) on sales of real estate, net: $60,657,000.00Operating adjustments reconciliation → Amortization of non-refundable entrance fees: $55,010,000.00Operating adjustments reconciliation → Increase (decrease) in accounts payable, accrued liabilities, and other liabilities: $29,850,000.00Operating adjustments reconciliation → Straight-line rents: $23,088,000.00Operating adjustments reconciliation → Other non-cash items: $13,716,000.00Operating adjustments reconciliation → Amortization of above (below) market lease intangibles: $12,905,000.00Operating adjustments reconciliation → Equity loss (income) from unconsolidated joint ventures: $6,774,000.00Operating adjustments reconciliation → Casualty-related loss (recoveries), net: $5,697,000.00Operating adjustments reconciliation → Impairments and loan loss reserves (recoveries), net: $3,754,000.00Operating adjustments reconciliation → Deferred income tax expense (benefit): $3,097,000.00Borrowings under bank line of credit and commercial paper → financing reconciliation: $13,741,850,000.00Proceeds from Janus Living public offerings, net of underwriting fees → financing reconciliation: $1,592,524,000.00Contributions from and issuance of noncontrolling interests → financing reconciliation: $760,000.00Issuance of common stock, net of offering costs → financing reconciliation: $733,000.00financing reconciliation → Net cash from financing activities: $1,064,978,000.00financing reconciliation → Repayments under bank line of credit and commercial paper: $13,324,706,000.00financing reconciliation → Dividends paid on common stock: $422,250,000.00financing reconciliation → Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt: $244,552,000.00financing reconciliation → Distributions to and redemption of noncontrolling interests: $164,136,000.00financing reconciliation → Repurchase of common stock: $101,561,000.00financing reconciliation → Noncontrolling interest issuance costs: $8,883,000.00financing reconciliation → Payments for debt extinguishment and deferred financing costs: $4,801,000.00Net cash used in investing activities → investing reconciliation: $505,976,000.00Proceeds from sales/principal repayments on loans receivable and other → investing reconciliation: $403,839,000.00Proceeds from the BX JV I and II transaction, net → investing reconciliation: $162,801,000.00Proceeds from sales of real estate, net → investing reconciliation: $146,960,000.00Distributions in excess of earnings from unconsolidated joint ventures → investing reconciliation: $15,905,000.00Proceeds from insurance recovery → investing reconciliation: $13,969,000.00investing reconciliation → Acquisitions of real estate: $542,338,000.00investing reconciliation → Development, redevelopment, and other major improvements of real estate: $299,158,000.00investing reconciliation → Joint venture buyout, net: $295,808,000.00investing reconciliation → Leasing costs, tenant improvements, and recurring capital expenditures: $66,061,000.00investing reconciliation → Investments in loans receivable and other: $44,153,000.00investing reconciliation → Investments in unconsolidated joint ventures: $1,932,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $537,702,000.00Net cash from operating activities → Cash sources and uses: $621,981,000.00Net cash from financing activities → Cash sources and uses: $1,064,978,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $1,718,685,000.00Cash sources and uses → Net cash used in investing activities: $505,976,000.00Net income (loss): $262,897,000.00Net income (loss)+$262.90 MDepreciation and amortization of real estate, in-place lease, and other intangibles: $573,124,000.00Depreciation & amortization+$573.12 MStock-based compensation amortization expense: $9,308,000.00Stock-based compensation+$9.31 MStock-based compensation issued as part of initial public offering of Janus Living, Inc.: $4,872,000.00Janus Living offering stock comp+$4.87 MAmortization of deferred financing costs and debt discounts (premiums): $17,264,000.00Debt cost amortization+$17.26 MStraight-line rents: -$23,088,000.00Straight-line rents−$23.09 MAmortization of above (below) market lease intangibles: -$12,905,000.00Market-lease amortization, net−$12.91 MAmortization of non-refundable entrance fees: -$55,010,000.00Entrance fee amortization−$55.01 MEquity loss (income) from unconsolidated joint ventures: -$6,774,000.00Joint venture equity results−$6.77 MDistributions of earnings from unconsolidated joint ventures: $905,000.00Equity-method distributions+$905.00 KDeferred income tax expense (benefit): -$3,097,000.00Deferred taxes & credits−$3.10 MImpairments and loan loss reserves (recoveries), net: -$3,754,000.00Asset impairments−$3.75 MLoss (gain) on debt extinguishments: $403,000.00Debt extinguishment gain & loss+$403.00 KLoss (gain) on sales of real estate, net: -$60,657,000.00Investment sale gain & loss−$60.66 MLoss (gain) upon change of control, net: -$138,343,000.00Control change gain & loss, net−$138.34 MCasualty-related loss (recoveries), net: -$5,697,000.00Insurance gain & loss−$5.70 MOther non-cash items: -$13,716,000.00Other non-cash items−$13.72 MDecrease (increase) in accounts receivable and other assets: $27,131,000.00Receivables & other assets+$27.13 MIncrease (decrease) in accounts payable, accrued liabilities, and other liabilities: -$29,850,000.00Payables & accrued liabilities−$29.85 MIncrease (decrease) in deferred revenue: $78,968,000.00Deferred revenue+$78.97 MNet cash from operating activities: $621,981,000.00Operating cash+$621.98 MOperating adjustments reconciliation: $711,975,000.00Borrowings under bank line of credit and commercial paper: $13,741,850,000.00Credit line borrowings+$13.74 BRepayments under bank line of credit and commercial paper: -$13,324,706,000.00Credit line repayments−$13.32 BIssuances and borrowings of term loans, senior unsecured notes, and mortgage debt: $0.00Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt: -$244,552,000.00Bank debt repaid−$244.55 MPayments for debt extinguishment and deferred financing costs: -$4,801,000.00Debt extinguishment costs−$4.80 MIssuance of common stock, net of offering costs: $733,000.00Equity issued+$733.00 KRepurchase of common stock: -$101,561,000.00Common stock repurchases−$101.56 MDividends paid on common stock: -$422,250,000.00Dividends paid−$422.25 MDistributions to and redemption of noncontrolling interests: -$164,136,000.00Paid to noncontrolling interests−$164.14 MProceeds from Janus Living public offerings, net of underwriting fees: $1,592,524,000.00From noncontrolling interests+$1.59 BContributions from and issuance of noncontrolling interests: $760,000.00Noncontrolling interests issued+$760.00 KNoncontrolling interest issuance costs: -$8,883,000.00Noncontrolling issuance costs−$8.88 MNet cash from financing activities: $1,064,978,000.00Financing cash+$1.06 Bfinancing reconciliation: $15,335,867,000.00Acquisitions of real estate: -$542,338,000.00Real estate acquisitions−$542.34 MJoint venture buyout, net: -$295,808,000.00Business acquisitions, gross−$295.81 MDevelopment, redevelopment, and other major improvements of real estate: -$299,158,000.00Real estate development−$299.16 MLeasing costs, tenant improvements, and recurring capital expenditures: -$66,061,000.00Leasing, tenant & capital costs−$66.06 MProceeds from sales of real estate, net: $146,960,000.00Real estate sales+$146.96 MProceeds from the BX JV I and II transaction, net: $162,801,000.00BX joint venture proceeds, net+$162.80 MInvestments in unconsolidated joint ventures: -$1,932,000.00Investments in affiliates−$1.93 MDistributions in excess of earnings from unconsolidated joint ventures: $15,905,000.00Distributions above earnings+$15.91 MProceeds from insurance recovery: $13,969,000.00Insurance proceeds+$13.97 MProceeds from sales/principal repayments on loans receivable and other: $403,839,000.00Loan & lease repayments+$403.84 MInvestments in loans receivable and other: -$44,153,000.00Loan investments & other−$44.15 MNet cash used in investing activities: -$505,976,000.00. Cash required to fund net payments.Investing cash−$505.98 Minvesting reconciliation: $1,249,450,000.00Cash sources and uses: $2,224,661,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $537,702,000.00Beginning cash$537.70 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $1,718,685,000.00Ending cash$1.72 BCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flowNot availableCash flow / Net income2.37×Operating cash flow ÷ net incomeNet cash change+$1.18 BEnding cash − beginning cash
Chart details

Healthpeak Properties, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
537,702,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
621,981,000 US dollars. Net cash provided.
Net income (loss)
262,897,000 US dollars
Depreciation and amortization of real estate, in-place lease, and other intangibles
573,124,000 US dollars
Stock-based compensation amortization expense
9,308,000 US dollars
Stock-based compensation issued as part of initial public offering of Janus Living, Inc.
4,872,000 US dollars
Amortization of deferred financing costs and debt discounts (premiums)
17,264,000 US dollars
Straight-line rents
negative 23,088,000 US dollars
Amortization of above (below) market lease intangibles
negative 12,905,000 US dollars
Amortization of non-refundable entrance fees
negative 55,010,000 US dollars
Equity loss (income) from unconsolidated joint ventures
negative 6,774,000 US dollars
Distributions of earnings from unconsolidated joint ventures
905,000 US dollars
Deferred income tax expense (benefit)
negative 3,097,000 US dollars
Impairments and loan loss reserves (recoveries), net
negative 3,754,000 US dollars
Loss (gain) on debt extinguishments
403,000 US dollars
Loss (gain) on sales of real estate, net
negative 60,657,000 US dollars
Loss (gain) upon change of control, net
negative 138,343,000 US dollars
Casualty-related loss (recoveries), net
negative 5,697,000 US dollars
Other non-cash items
negative 13,716,000 US dollars
Decrease (increase) in accounts receivable and other assets
27,131,000 US dollars
Increase (decrease) in accounts payable, accrued liabilities, and other liabilities
negative 29,850,000 US dollars
Increase (decrease) in deferred revenue
78,968,000 US dollars
Investing activities
negative 505,976,000 US dollars. Net cash used.
Acquisitions of real estate
negative 542,338,000 US dollars
Joint venture buyout, net
negative 295,808,000 US dollars
Development, redevelopment, and other major improvements of real estate
negative 299,158,000 US dollars
Leasing costs, tenant improvements, and recurring capital expenditures
negative 66,061,000 US dollars
Proceeds from sales of real estate, net
146,960,000 US dollars
Proceeds from the BX JV I and II transaction, net
162,801,000 US dollars
Investments in unconsolidated joint ventures
negative 1,932,000 US dollars
Distributions in excess of earnings from unconsolidated joint ventures
15,905,000 US dollars
Proceeds from insurance recovery
13,969,000 US dollars
Proceeds from sales/principal repayments on loans receivable and other
403,839,000 US dollars
Investments in loans receivable and other
negative 44,153,000 US dollars
Financing activities
1,064,978,000 US dollars. Net cash provided.
Borrowings under bank line of credit and commercial paper
13,741,850,000 US dollars
Repayments under bank line of credit and commercial paper
negative 13,324,706,000 US dollars
Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt
0 US dollars
Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt
negative 244,552,000 US dollars
Payments for debt extinguishment and deferred financing costs
negative 4,801,000 US dollars
Issuance of common stock, net of offering costs
733,000 US dollars
Repurchase of common stock
negative 101,561,000 US dollars
Dividends paid on common stock
negative 422,250,000 US dollars
Distributions to and redemption of noncontrolling interests
negative 164,136,000 US dollars
Proceeds from Janus Living public offerings, net of underwriting fees
1,592,524,000 US dollars
Contributions from and issuance of noncontrolling interests
760,000 US dollars
Noncontrolling interest issuance costs
negative 8,883,000 US dollars
Operating adjustment reconciliation
711,975,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
15,335,867,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
1,249,450,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
1,718,685,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
2,224,661,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,180,983,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.37×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $359.08M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
Healthpeak Properties, Inc. (DOC) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!